Switching STudy of Kidney TRansplant PAtients with Tremor to LCP‐TacrO (STRATO): an open‐label, multicenter, prospective phase 3b study

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 9, 2015-09 ,pp. : 796-805

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 471-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

An open‐label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 12, 2015-12 ,pp. : 1395-1405

John Wiley & Sons Inc

Access to resources Recommend Favorite

OC15.01: In utero treatment of congenital cytomegalovirus infection with Valacyclovir in a multicentre, open‐label, phase II study

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 48, Iss. S1, 2016-09 ,pp. : 27-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 120-127

John Wiley & Sons Inc

Access to resources Recommend Favorite